Full Description
In this issue of Urologic Clinics of North America, guest editors Drs. Michael L. Blute and Steven L. Chang bring their considerable expertise to the topic of Renal Cancer: Old and New Paradigms. Recent significant advances in the management of renal cancer have expanded beyond simply eliminating disease to preserving and optimizing quality of life. In this issue, top experts highlight historical perspectives as well as current status and future treatments of renal cancer.
Contains 13 practice-oriented topics on biomarkers for the detection and surveillance of renal cancer; the changing role of renal mass biopsy; renal cysts: an oncological conundrum; the surgical management of renal cancer with inferior vena caval thrombus; integrating surgery in the multidisciplinary care of advanced renal cancer; and more.
Provides in-depth clinical reviews on renal cancer, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Contents
Radiologist's Disease: Imaging for Renal Cancer
Evolution in the Pathologic Classification of Renal Neoplasia
Biomarkers for the Detection and Surveillance of Renal Cancer
Diseases of Hereditary Renal Cell Cancers
The Changing Role of Renal Mass Biopsy
Cystic Renal Masses: Old and New Paradigms
Long-Term Renal Function Following Renal Cancer Surgery: Historical Perspectives, Current Status, and Future Considerations
Surgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus
The Promise of Neoadjuvant and Adjuvant Therapies for Renal Cancer
The Great Masquerader's New Wardrobe in the Modern Era: The Paraneoplastic Manifestations of Renal Cancer
Integrating Surgery in the Multidisciplinary Care of Advanced Renal Cell Carcinoma
Radiation Therapy in the Treatment of Localized and Advanced Renal Cancer
The Changing Landscape of Immunotherapy for Advanced Renal Cancer
